SCHEMBL6895924

SCHEMBL6895924

C[C@@H](O)[C@@H](N)C(NCc1ccc(C(F)(F)F)cc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
CASR P41180 2/20 0.45
TMEM97 Q5BJF2 4/20 0.42
KCNH2 Q12809 3/20 0.42
NR3C2 P08235 1/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GPR55 Q9Y2T6 1/20 0.39
TACR1 P25103 1/20 0.39
DNM1 Q05193 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6887059 0.89 TACR1 (0.50) TACR1
SCHEMBL164926 0.86 HTR2A (0.50) KCNH2NR3C2LMNACYP1A2CYP2D6
SCHEMBL6895745 0.86 LMNA (0.47) ALDH1A1CASRLMNAMAPK1HTT
SCHEMBL6892550 0.84 EPHX1 (0.45) ALDH1A1CASRLMNAMAPK1HTT
SCHEMBL6895808 0.84 SMN1; SMN2 (0.57) ALDH1A1LMNAMAPK1HTTNPSR1
SCHEMBL6887798 0.83 GAA (0.45) ALDH1A1LMNAMAPK1HTTNPSR1
SCHEMBL6894820 0.83 CYP1A2 (0.60) ALDH1A1NR3C2LMNAMAPK1HTT
SCHEMBL6886251 0.81 TDP1 (0.52) ALDH1A1CASRLMNAMAPK1HTT
SCHEMBL6892044 0.79 LMNA (0.38) ALDH1A1LMNAMAPK1HTTNPSR1
SCHEMBL6894577 0.78 SMN1; SMN2 (0.40) ALDH1A1LMNAMAPK1HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed